High Growth Tech Stocks to Watch in October 2024

Like
Comment
Favorite

High Growth Tech Stocks to Watch in October 2024

Simply Wall St.10-17

The United States market has experienced a notable upswing, rising 1.2% over the last week and 35% over the past year, with earnings projected to grow by 15% annually. In this environment, identifying...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

No comments yet

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2476179266?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/CFs_WULfFYYyM1iyv.feAw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/7137ef364be97d9882cfa4ec57169a99","is_english":true,"pubTime":"2024-10-17 22:05","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2476179266","market":"us","top_or_hot":-1,"title":"High Growth Tech Stocks to Watch in October 2024","media":"Simply Wall St.","content":"<div>\n<p>The United States market has experienced a notable upswing, rising 1.2% over the last week and 35% over the past year, with earnings projected to grow by 15% annually. In this environment, identifying...</p>\n\n<a href=\"https://finance.yahoo.com/news/high-growth-tech-stocks-watch-140559003.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>High Growth Tech Stocks to Watch in October 2024</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHigh Growth Tech Stocks to Watch in October 2024\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-17 22:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/high-growth-tech-stocks-watch-140559003.html><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The United States market has experienced a notable upswing, rising 1.2% over the last week and 35% over the past year, with earnings projected to grow by 15% annually. In this environment, identifying...</p>\n\n<a href=\"https://finance.yahoo.com/news/high-growth-tech-stocks-watch-140559003.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1061106388.HKD","symbol_name":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","start_time":0,"source_url":"https://finance.yahoo.com/news/high-growth-tech-stocks-watch-140559003.html","article_id":"2476179266","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/CFs_WULfFYYyM1iyv.feAw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/7137ef364be97d9882cfa4ec57169a99"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2476179266","pubTimestamp":1729173959,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"The United States market has experienced a notable upswing, rising 1.2% over the last week and 35% over the past year, with earnings projected to grow by 15% annually. In this environment, identifying high growth tech stocks involves looking for companies that not only capitalize on technological innovation but also demonstrate strong potential for sustained revenue expansion in line with these optimistic market conditions.Top 10 High Growth Tech Companies In The United States. Click here to see the full list of 253 stocks from our US High Growth Tech and AI Stocks screener.NasdaqCM:CPRX Earnings and Revenue Growth as at Oct 2024. Overview: Amgen Inc. is a global biotechnology company focused on discovering, developing, manufacturing, and delivering human therapeutics, with a market capitalization of approximately $172.82 billion.Operations: The company generates revenue primarily from its Human Therapeutics segment, which contributed $30.93 billion. The focus on human therape","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","AMGN":"安进","WIX":"Wix.Com Ltd","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","LU0122379950.USD":"贝莱德世界健康科学A2","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","SG9999001440.SGD":"United Global Dividend Equity Fund A SGD Dist","BK4585":"ETF&股票定投概念","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","BK4139":"生物科技","BK4534":"瑞士信贷持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","LU2242652126.USD":"FIDELITY FUNDS GLOBAL DIVIDENDS PLUS \"A\" (USD) INC","BK4566":"资本集团","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","LU1983299246.USD":"SCHRODER ISF HEALTHCARE INNOVATION \"A\" (USD) ACC","LU2112291526.USD":"BGF WORLD HEALTHSCIENCE \"A4\" (USD) INC","BK4588":"碎股","LU2242646821.SGD":"Fidelity Global Dividend Plus A-MINCOME(G)-SGD","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","CPRX":"Catalyst Pharmaceutical Partners","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","BK4581":"高盛持仓","LU0058720904.USD":"联博国际健康护理基金A"},"translate_title":"2024年10月值得关注的高增长科技股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"WIX":0.9,"AMGN":0.9,"CPRX":0.9},"content_text":"The United States market has experienced a notable upswing, rising 1.2% over the last week and 35% over the past year, with earnings projected to grow by 15% annually. In this environment, identifying high growth tech stocks involves looking for companies that not only capitalize on technological innovation but also demonstrate strong potential for sustained revenue expansion in line with these optimistic market conditions.\nTop 10 High Growth Tech Companies In The United States\n\n\n\nName\nRevenue Growth\nEarnings Growth\nGrowth Rating\n\n\nSuper Micro Computer\n20.86%\n27.98%\n★★★★★★\n\n\nSarepta Therapeutics\n23.67%\n43.83%\n★★★★★★\n\n\nTG Therapeutics\n28.39%\n43.54%\n★★★★★★\n\n\nInvivyd\n42.91%\n70.39%\n★★★★★★\n\n\nArdelyx\n27.19%\n66.44%\n★★★★★★\n\n\nAmicus Therapeutics\n20.33%\n62.45%\n★★★★★★\n\n\nTravere Therapeutics\n27.74%\n70.00%\n★★★★★★\n\n\nMediaAlpha\n22.72%\n61.31%\n★★★★★★\n\n\nSeagen\n22.57%\n71.80%\n★★★★★★\n\n\nImmunoGen\n26.00%\n45.85%\n★★★★★★\n\n\n\nClick here to see the full list of 253 stocks from our US High Growth Tech and AI Stocks screener.\nHere's a peek at a few of the choices from the screener.\nCatalyst Pharmaceuticals\nSimply Wall St Growth Rating: ★★★★★☆\nOverview: Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company that develops and commercializes therapies for rare neuromuscular and neurological diseases in the United States, with a market cap of $2.57 billion.\nOperations: Catalyst Pharmaceuticals focuses on the development and commercialization of drug products for rare neuromuscular and neurological diseases, generating $434.48 million in revenue.\nCatalyst Pharmaceuticals is actively pursuing growth through strategic acquisitions and partnerships, signaling a proactive approach to expanding its market presence. Recently, the company revised its full-year revenue forecast upwards to between $455 million and $475 million, reflecting a robust financial outlook. This upward revision follows a strong performance in the second quarter of 2024, where revenues surged by 23% year-over-year to $122.71 million. Catalyst's commitment to innovation is further underscored by its R&D efforts; however, specific figures on recent R&D expenses are not provided here. These strategic moves, combined with an expected annual profit growth of 20.9%, position Catalyst well within the competitive landscape of high-growth tech sectors in healthcare and biotechnology.\n\nNavigate through the intricacies of Catalyst Pharmaceuticals with our comprehensive health report here.\nLearn about Catalyst Pharmaceuticals' historical performance.\n\n\n\n\n  NasdaqCM:CPRX Earnings and Revenue Growth as at Oct 2024\n \n\nAmgen\nSimply Wall St Growth Rating: ★★★★☆☆\nOverview: Amgen Inc. is a global biotechnology company focused on discovering, developing, manufacturing, and delivering human therapeutics, with a market capitalization of approximately $172.82 billion.\nOperations: The company generates revenue primarily from its Human Therapeutics segment, which contributed $30.93 billion. The focus on human therapeutics underscores its core business model in the biotechnology sector.\nAmgen, while not leading in high-growth tech, shows promise with a 23.2% projected annual earnings growth over the next three years, outpacing the US market forecast of 15.2%. This growth is supported by robust R&D investments which have consistently aligned with revenue increases—last year's R&D expenses were $5 billion, about 16.7% of its $30 billion revenue. Recent trials like the Phase 3 MINT for UPLIZNA underscore Amgen's commitment to innovation in biotechnology, potentially boosting future revenues and strengthening its market position despite a current annual revenue growth forecast of only 3%.\n\nClick here to discover the nuances of Amgen with our detailed analytical health report.\nExplore historical data to track Amgen's performance over time in our Past section.\n\n\n\n\n  NasdaqGS:AMGN Revenue and Expenses Breakdown as at Oct 2024\n \n\nWix.com\nSimply Wall St Growth Rating: ★★★★★☆\nOverview: Wix.com Ltd. operates as a cloud-based web development platform catering to registered users and creators globally, with a market capitalization of approximately $9.61 billion.\nOperations: The company generates revenue primarily from its Internet Software & Services segment, amounting to $1.65 billion. As a cloud-based platform, it supports users and creators in web development worldwide.\nWix.com, a player in the tech arena, is steering through an impressive growth trajectory with a forecasted annual revenue increase of 11.4%, outpacing the US market average of 8.8%. This growth is underpinned by strategic partnerships, such as the recent alliance with Moneris Solutions, enhancing its e-commerce capabilities through omnichannel solutions. Notably, Wix's commitment to innovation is evident in its R&D spending which aligns closely with revenue gains; last year alone, R&D expenses accounted for a significant portion of their revenue at 32.0%. Additionally, the company's proactive approach at conferences and product enhancements—like the launch of AI-powered tools for content generation—showcases its dedication to maintaining a competitive edge in rapidly evolving tech landscapes.\n\nClick to explore a detailed breakdown of our findings in Wix.com's health report.\nReview our historical performance report to gain insights into Wix.com's's past performance.\n\n\n\n\n  NasdaqGS:WIX Revenue and Expenses Breakdown as at Oct 2024\n \n\nTaking Advantage\n\nUnlock our comprehensive list of 253 US High Growth Tech and AI Stocks by clicking here.\nHave a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.\nMaximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.\n\nInterested In Other Possibilities?\n\nExplore high-performing small cap companies that haven't yet garnered significant analyst attention.\nFuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.\nFind companies with promising cash flow potential yet trading below their fair value.\n\n This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.\nCompanies discussed in this article include NasdaqCM:CPRX NasdaqGS:AMGN and NasdaqGS:WIX.\nHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}